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The small intestine epithelium renews every 2 to 5 days, making it one of the most regenerative mammalian tissues. Genetic inducible fate mapping studies have identified two principal epithelial stem cell pools in this tissue. One pool consists of columnar Lgr5-expressing cells that cycle rapidly and are present predominantly at the crypt base 1 . The other pool consists of Bmi1-expressing cells that largely reside above the crypt base 2 . However, the relative functions of these two pools and their interrelationship are not understood. Here we specifically ablated Lgr5-expressing cells in mice using a human diphtheria toxin receptor (DTR) gene knocked into the Lgr5 locus. We found that complete loss of the Lgr5-expressing cells did not perturb homeostasis of the epithelium, indicating that other cell types can compensate for the elimination of this population. After ablation of Lgr5-expressing cells, progeny production by Bmi1-expressing cells increased, indicating that Bmi1-expressing stem cells compensate for the loss of Lgr5-expressing cells. Indeed, lineage tracing showed that Bmi1-expressing cells gave rise to Lgr5-expressing cells, pointing to a hierarchy of stem cells in the intestinal epithelium. Our results demonstrate that Lgr5-expressing cells are dispensable for normal intestinal homeostasis, and that in the absence of these cells, Bmi1-expressing cells can serve as an alternative stem cell pool. These data provide the first experimental evidence for the interrelationship between these populations. The Bmi1-expressing stem cells may represent both a reserve stem cell pool in case of injury to the small intestine epithelium and a source for replenishment of the Lgr5-expressing cells under nonpathological conditions.
Two types of stem cells have been described in the small intestine based on location and cycling dynamics [1] [2] [3] [4] 32, 33 . Fast-cycling stem cells express markers including Lgr5, Cd133 (also known as Prom1) and Sox9 (refs 1, 5, 6) and are present throughout the intestine. Also known as crypt base columnar cells (CBCs), these slender cells populate the crypt and villi within 3 days, and are interspersed among the Paneth cells that support them 7, 8 . Slower-cycling stem cells, marked by enriched expression of Bmi1 or mouse Tert (mTert), represent a rarer cell population 2, 9 . These cells form a descending gradient from proximal to distal regions of the intestine, such that they are more prevalent in the duodenum than in the colon. Despite their rarity, Bmi1-expressing stem cells are crucial for crypt maintenance 2 .
To study the function of Lgr5-expressing cells, we replaced the first coding exon of Lgr5 with two distinct cassettes. The first consisted of a dsRED-IRES-CreERT2 sequence to enable genetic lineage tracing studies by tamoxifen (TAM)-inducible expression of Cre in Lgr5-expressing cells ( Supplementary Fig. 1a, Lgr5 CreER allele). The second cassette contained enhanced green fluorescent protein (EGFP) linked in frame to a human DTR cDNA ( Supplementary Fig. 1a , Lgr5 DTR allele), producing a fusion protein. Consistent with previous reports 1 
, one injection of TAM in Lgr5
CreER ;R26R mice marked Lgr5-expressing stem cells in a mosaic fashion and led to generation of labelled progeny for more than 60 days ( Supplementary Fig. 1b) . Expression of DTR-EGFP in Lgr5 DTR mice functioned as a reporter for Lgr5 expression (Fig. 1a ) and also conferred diphtheria toxin (DT) sensitivity on CBCs. Expression of EGFP in mice carrying the Lgr5 DTR allele was detected at the membrane of cycling CBCs in every crypt ( Supplementary Fig.  1c -e, CBCs are marked by asterisks).
We next set out to test the effects of eliminating Lgr5-expressing cells by administering DT to Lgr5 DTR mice. Twenty-four hours after DT administration, all EGFP-positive cells were depleted, including CBCs (Fig. 1a, b , j, k, p, q). Loss of Lgr5-expressing cells was further confirmed by the absence of Lgr5 messenger RNA (Fig. 1d, e) and was accompanied by extensive apoptosis at the base of the crypts, with shedding of dead cells into the lumen (Fig. 1m, n) .
After sustained DT exposure for 10 days, both the EGFP reporter and Lgr5 mRNA were completely absent from the base of the crypts (Fig. 1c, f and Supplementary Fig. 2 ) but, notably, crypt architecture was comparable to controls (Fig. 1g , i, j, l). Proliferating CBCs were absent from the crypt (Fig. 1l, r) , such that the crypt base was occupied mostly or entirely by Paneth cells ( Supplementary Fig. 3a, b) . The extensive apoptosis detected 24 h after DT treatment had significantly decreased by day 10 (compare Fig. 1n with o) but was still detectable. No increase in crypt fission after DT treatment was observed by haematoxylin and eosin staining at any time point (Fig. 1g-i) .
Because Lgr5-expressing cells have been proposed to have a critical role in renewal of the intestine, it was surprising that the architecture of the intestinal epithelium was essentially intact after ablation of Lgr5-expressing CBCs (Fig. 1g-i) . Within the villi, very little change in the total number of endocrine cells was observed ( Supplementary Fig. 3c, d) , and goblet cells were abundant in the crypts and villi (Supplementary Fig. 3g, h, j) . Upon CBC ablation, Paneth cells were found at the bottom of the crypts and in some cases were mislocalized to the villi ( Supplementary Fig. 3a , b and data not shown); additionally, migration of cells as assessed by BrdU pulse-chase labelling was normal (Supplementary Fig. 4 ). The only major difference from controls that we observed was in the secretory cell lineage; the number of chromogranin-A-positive enteroendocrine cells in the crypts doubled after DT administration for 10 days ( Supplementary Fig. 3e, f, i) .
We did not detect any Lgr5-expressing CBCs using either the EGFP reporter or in situ hybridization after 10 days of DT (Fig. 1c, f and Supplementary Fig. 2 ), but it was still possible that a few CBCs could have escaped ablation and repopulated the epithelium, as a similar scenario was reported in c-Myc and Ascl2 conditional null mice 10, 11 . To address this possibility directly, we visualized Lgr5-expressing cell activity during DT selection by producing Lgr5 DTR/CreER ;R26R mice. These mutant mice carried two null alleles at the Lgr5 locus, of which one enabled ablation of Lgr5-expressing cells and the other enabled lineage tracing of any possibly remaining Lgr5-expressing cells. These mice died at postnatal day (P)1, consistent with previous reports that Lgr5 null mice are not viable 12 . To analyse the postnatal gut, we grew pieces of small intestine from embryonic day (E)15 Lgr5 DTR/CreER ;R26R embryos under the kidney capsule of immunocompromised mice for three weeks, at which point they formed crypts comparable to P17 intestine ( Fig. 2a-e) 
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. After 10 days of TAM treatment, columns of blue cells emanated from the crypt base, and progeny of Lgr5-expressing cells differentiated into all four major cell types of the intestinal epithelium ( Fig. 2a-e) . Concomitant administration of DT and TAM for 10 days eradicated all EGFP-positive CBCs (Fig. 2g) , and no cells descended from Lgr5-expressing cells were observed (Fig. 2f) , confirming that the Lgr5 DTR allele leads to complete elimination of these cells. Importantly, no abnormalities in graft morphology, differentiation or proliferation were observed in these mice compared to controls (Fig. 2a-j) .
Although Lgr5-expressing cells were completely depleted within 24 h of DT treatment, persistence of apoptotic bodies at the crypt base throughout the 10-day DT treatment suggested that Lgr5-expressing CBCs were continuously generated and eliminated during the treatment (Fig. 1n, o) . This notion was supported by the quick recovery of Lgr5-expressing cells between 48 to 96 h after the final dose of DT ( Fig. 1s-v) . To follow the fate of the newly generated Lgr5-expressing cells, mice implanted with Lgr5 DTR/CreER ;R26R embryonic intestine fragments in the kidney capsule were allowed to recover for 6 days in the presence of TAM following 6 days of DT treatment. A row of blue cells emanated from the crypt base ( Supplementary Fig. 5a ), indicating that the newly formed Lgr5-expressing stem cells (Supplementary Fig. 5b , GFP-positive cells) gave rise to progeny that migrated out of the crypt. When the converse experiment was performed by 
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injecting TAM for 6 days and then dosing with DT from days 6 to 12, blue cells were only present in the upper region of the villi (Supplementary Fig. 5c ), indicating that progeny of Lgr5-expressing cells marked between day 1 and 6 migrated out of the crypts into the villi, but that during DT treatment between days 6 and 12, Lgr5-expressing stem cells were no longer available ( Supplementary Fig. 5d , absence of GFP signal) to supply labelled (blue) progeny to replenish the epithelium.
To study the long-term effects of CBC ablation, we isolated crypts from Lgr5 DTR/1 mice to perform in vitro crypt organoid cultures 14 . Crypts depleted of Lgr5-expressing CBCs by treatment for 10 days with DT, as indicated by absence of GFP expression, gave rise to organoids with similar efficiency as wild-type controls ( Supplementary Fig. 6a,  b) . These could be passaged in vitro in DT for up to 2 months without losing their ability to expand and proliferate. No Lgr5-expressing (GFP-positive) cells were detected in organoid epithelium as long as the organoids were maintained in medium containing DT (Supplementary Fig. 6d) . However, when DT was removed from the culture medium, Lgr5-expressing cells reappeared at the bottom of crypt-like structures within 3 days (Supplementary Fig. 6c, GFP-positive cells) .
Because we found that Lgr5-expressing CBCs were dispensable for crypt maintenance, we next asked whether Bmi1-expressing stem cells were mobilized to compensate for the loss of the Lgr5-expressing stem cells. Mouse BMI1 regulates self-renewal of haematopoietic and neuronal stem cells 15 . We used a GFP knock-in allele (Bmi1 GFP/1 ) to monitor Bmi1 gene expression 16 . Bmi1-expressing GFP-positive cells were most commonly observed at positions 3 to 6 above the crypt base (Fig. 3a) , consistent with the Bmi1 mRNA expression pattern in the small intestine ;Bmi1 GFP/1 mice after 9 days of DT treatment, the number of GFP-positive cells per crypt increased three fold (Fig. 3a-d and Supplementary Fig. 7a ), and the proportion of crypts containing either single or multiple GFP-expressing cells increased by 40% compared to control animals ( Supplementary  Fig. 7b ). Of note, 55% of the total number of GFP-positive crypts in Lgr5 DTR/1 ;Bmi1 GFP/1 mice now contained multiple GFP-positive cells ( Fig. 3d and Supplementary Fig. 7b ), compared with only 22% in Bmi1 GFP/1 control animals. To trace the fate of cells descended from Bmi1-expressing cells after elimination of Lgr5-expressing CBCs, we generated a Bmi1CreER bacterial artificial chromosome (BAC) transgenic allele (Supplementary Fig. 8 ). Labelling kinetics using the Bmi1-CreER transgenic line crossed with the R26R reporter were identical to previously reported results using the Bmi1
CreER knock-in allele 2 (Fig. 3f ). Bmi1-CreER;R26R;Lgr5 DTR/1 animals were treated with alternating doses of DT and TAM per day for 7 days (Fig. 3e) . Because Bmi1-expressing cells are most abundant in the first 5 cm of the duodenum, we focused our analysis on this region. Consistent with the increased number of Bmi1-expressing cells (Supplementary Fig. 7a ), the proportion of LacZpositive crypts (either partially or fully labelled) also increased 34% upon loss of Lgr5-expressing CBCs (Supplementary Fig. 7c ). The most marked difference was in the number of fully labelled crypts. Only 2.3% of crypts were fully labelled in Bmi1CreER;R26R control mice during a 6-day lineage tracing period, which was comparable with previous studies using a Bmi1
CreER knock-in allele 2 . Upon loss of Lgr5-expressing CBCs, the number of fully labelled crypts increased approximately 15-fold (Fig. 3h, i and Supplementary Fig. 7c ). These results indicate that in the absence of Lgr5-expressing cells, Bmi1-expressing cells are capable of directly giving rise to all intestinal cell types without going through Lgr5-positive intermediate cells. However, Bmi1-expressing stem cells did not give rise to an increased number of labelled crypts in more distal regions of small intestine and colon upon loss of Lgr5-expressing CBCs (Fig. 3f, g ), indicating that alternative stem cell pools must compensate for the loss of Lgr5-expressing stem cells in distal regions of the gut.
Lastly, we tested whether Bmi1-expressing cells give rise to Lgr5-expressing cells under normal conditions. Because Bmi1-and Lgr5-expressing cells represent distinct although overlapping cell populations, we carried out a series of short-term pulse-chase experiments using Bmi1-CreER;R26R;Lgr5 DTR/1 mice. Twenty-four hours after TAM administration, most of the b-galactosidase (b-gal)-positive cells appeared as individuals, reflecting the normal pattern of Bmi1 expression (Fig. 4a) Fig. 4a-c) . This observation is consistent with a previous report stating that Bmi1 mRNA expression (via quantitative polymerase chain reaction (qPCR) analysis) was readily detectable in Lgr5-positive cells 11 . Later, between 48-72 h, clonal expansion 
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from Bmi1-expressing cells was evident, as b-gal/GFP double-positive cells now appeared as doublets or triplets (Fig. 4d-i) . We scored a total of 500 crypts at each time point and found that although a few cells were b-gal/GFP double positive (that is, expressing both Bmi1 and Lgr5) at 24 h after TAM induction, this number doubled at 48 h (Fig. 4j, k) . Similarly, lineage tracing from Bmi1-expressing cells carried out in mice treated for 6 days with DT and allowed to recover for 72 h (Fig. 4l) demonstrated that newly formed Lgr5-positive cells at the bottom of the crypts arose from Bmi1-expressing cells (Fig. 4m-o) . Together, these data show that Bmi1-expressing cells can give rise to Lgr5-expressing cells both under normal physiological conditions and after insults that deplete CBCs. Similar to our observation, mTertexpressing stem cells could also give rise to Lgr5-positive cells over a 5-day lineage tracing period 9 . 
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Our data support the existence of two stem cell pools in the epithelium of the small intestine: an actively proliferating stem cell compartment responsible for the daily maintenance of the intestine epithelium that is characterized by the expression of Lgr5, Ascl2 and Olfm4 (refs 1, 11, 17) and a distinct pool of stem cells expressing Bmi1. Our results lend support to the two-stem-cell pool model that is based on computational approaches 18 , and provide experimental evidence for recent models predicting that the intestine could fully recover after complete elimination of cellular subpopulations deemed to be functional stem cells 19 . Our data do not support the recent proposal that Bmi1-expressing cells are exclusively a subset of Lgr5-expressing cells 11 ; rather they indicate that under normal circumstances, Bmi1-positive stem cells are upstream of rapidly cycling, Lgr5-expressing stem cells and replenish the pool of active stem cells, either to avoid exhaustion of actively cycling stem cells or to prevent the accumulation of damaged cells that may lead to the development of tumours. Importantly, we also demonstrate that when the Lgr5-expressing cell compartment is eliminated by DT treatment, Bmi1-expressing cells can increase in number, presumably as a compensatory mechanism. Under these conditions, Bmi1-expressing cells contribute directly to the generation of all cell types of the intestinal epithelium to produce a functional organ until the rapidly cycling stem cell compartment is able to recover. Although it has been proposed that Bmi1-expressing stem cells are quiescent 2 , this remains to be conclusively demonstrated.
Distinct stem cell pools with differing cycling dynamics have previously been observed in the hair follicle and in blood, organs that, like the intestine, undergo regular bouts of proliferation and regeneration [20] [21] [22] . The factors that regulate the interplay between discrete populations of stem cells, and the precise hierarchical relationships among such populations, remain to be characterized. Although we have found that loss of Lgr5-positive cells is sustainable under short-term conditions in vivo, it remains to be determined whether such a scenario can persist for longer periods of time. Interestingly, depletion of Paneth cells, which are thought to be important for the maintenance of CBCs 7 , can be tolerated by mice for over 6 months without significant structural defects of the epithelium 23, 24 , supporting the idea that the intestine can function normally in the absence of CBCs. It will be important to determine how different stem cell populations sense the activity of other populations, whether rapidly cycling cells can repopulate more quiescent stem cell populations, and whether additional subpopulations of stem cells exist.
METHODS SUMMARY
Mice. Lgr5
CreER/1 and Bmi1-CreER alleles were generated as described in Methods. Bmi1 GFP/1 mice were provided by I. Weissman 16 . All studies and procedures involving animal subjects were approved by the Institutional Animal Care and Use Committees of Genentech and the University of California, San Francisco, and were conducted strictly in accordance with the approved animal handling protocol.
METHODS
Lgr5 and Bmi1 vector construction. The constructs for targeting the C57BL/6 Lgr5 locus and the Bmi1 BAC transgene were made using a combination of recombineering, DNA synthesis and standard molecular cloning techniques 25, 26 . For Lgr5, a 7,213 bp fragment (assembly NCBI37/mm9, chr10:115,020,315-115,027,527) from a C57BL/6 BAC (RP23 library) was first retrieved into plasmid pBlight-TK 25 . To generate the DTR-EGFP KI vector for Lgr5, a DTR-EGFP-pAloxP-Neo-loxP cassette was synthesized (Blue Heron/Origene, DTR-EGFP sequence was based on that described previously 27 , and inserted right after the ATG of Lgr5 (chr10:115,024,547, reverse strand), deleting the remainder of exon 1 and splice donor of intron 1 (a 212 bp deletion). To generate the CreERT2 KI vector, a dsRed2-IRES-CreERT2-pA-Frt-neo-Frt cassette was synthesized (Blue Heron/Origene) and inserted at the same position as the DTR-EGFP cassette. The final vectors were confirmed by DNA sequencing.
The Lgr5 KI vectors were linearized with NotI and C57BL/6 C2 embryonic stem cells were targeted using standard methods (G418-positive and gancyclovirnegative selection). Positive clones were identified using PCR and taqman analysis, and confirmed by sequencing of the modified locus. Correctly targeted embryonic stem cells were transfected with a Cre or Flpe plasmid, respectively, to remove the Neo cassette. The modified embryonic stem cells were then injected into blastocysts using standard techniques, and germline transmission was obtained after crossing the resulting chimaeras with C57BL/6N females.
For Bmi1, a 210 kb C57BL/6 BAC (RP23-181D14, assembly NCBI37/mm9, chr2:18,464,619-18,674,471) was obtained and characterized by DNA fingerprinting. The BAC contains the Bmi1 locus and considerable 59 and 39 flanking sequence. An IRES-CreERT2-pA-frt-Neo-frt cassette was synthesized (Blue Heron/Origene) and inserted, using recombineering, 85 bp 39 of the Bmi1 stop codon (after position chr2: 18, 606, 193) . Neo was then removed by transforming the modified BAC into arabinose-induced, SW105 cells 28, 29 expressing the yeast protein Flp. C57BL/6 transgenic mice carrying the modified Bmi1 BAC were obtained using standard pronuclear microinjection methods 30 and characterized. We analysed the Lgr5 DTR/1 mice at 24 h after DT administration (50 mg k
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, intraperitoneal injection, n 5 3), at 10 days of DT treatment (50 mg kg 21 every other day for 10 days, n 5 5), 48 h recovery (n 5 3) and 96 h recovery time points after four doses of DT (n 5 2). The DT treatment could not be extended beyond 10 days due to severe liver toxicity apparently mediated by a subset of Lgr5-DTR-EGFP-expressing hepatocytes. We analysed Bmi1CreER;R26R;Lgr5 DTR/1 at 24 h (n 5 2), 48 h (n 5 2) and 72 h (n 5 2) after TAM injection. Two-hundred and fifty b-gal-positive crypts were scored per mouse. Renal capsule explants. 3-5-mm small intestine pieces from E15 Lgr5 DTR/CreER embryos (n 5 3) were grafted under the renal capsule of 6-8-week-old athymic nu/nu mice and allowed to develop for 3 weeks. We treated Lgr5 DTR/CreER ;R26R renal grafts with 10 days TAM (n 5 5), 10 days DT/TAM (n 5 5), 6 days DT followed by 6 days TAM (n 5 5) and 6 days TAM followed by 6 days DT (n 5 5). Some GFP expression was seen outside of the CBC region due to perdurance of GFP protein as well as upregulation of the Lgr5 locus when Lgr5 is deleted 12 . DT cell ablation. Mice (between 6 and 12 weeks old) were given DT at 50 mg kg 21 every 48 h through intraperitoneal injections. TAM labelling experiments. Mice (between 6 and 12 weeks old) were given 5 mg TAM in corn oil through intraperitoneal injection. Transmission electron microscopy. The tissues were fixed in 1/2 Karnovsky's fixative (2% paraformaldehyde (PFA), 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2), washed in the same buffer, and post-fixed in 1% osmium tetroxide. The samples were then dehydrated through a series of ethanol, followed by propylene oxide and embedded in Eponate 12 (Ted Pella). Thin sections were stained with uranyl acetate and lead citrate and examined using a Philips CM12 or JEOL JEM-1400 TEM. Histology, immunohistochemistry and immunofluorescence. Animals were perfused with 2% PFA. Small intestine and colon were flushed with 2% PFA and fixed in 4% PFA overnight. Half of the materials were cryo-protected, embedded in OCT, and sectioned at 6 mm for immunofluorescence. The other half of the materials were paraffin embedded, sectioned at 3 mm for histology and immunohistochemistry. Antibodies: Ki67 (Neomarker), cleaved caspase 3 (Cell Signaling), GFP (Novus), chromogranin A (Neomarkers), b-gal (Cappel). In situ hybridization and X-GAL staining. Full-length Lgr5 cDNA was cloned into the pGEM vector to make anti-sense DIG-probe. Protocols for in vitro transcription and in situ hybridization were as described previously 31 . Whole-mount X-GAL staining was performed as described 2 .
Crypt organoid culture. Crypt isolation and culture were performed as described 14 .
